• Successful A$3.5M capital raise through share placement
• Funds to accelerate commercialization of Life Sciences and Advanced Battery Tech products
• Near-term targets include new commercial supply agreements and strategic partnerships

AnteoTech Ltd (ASX: ADO) has announced a successful capital raise of A$3.5 million (net of costs) through a placement of new fully paid ordinary shares at A$0.0155 (1.55 cents) per share to institutional, sophisticated and professional investors. Each participant in the Placement will receive attaching options, with half being listed options exercisable at A$0.035 (3.5 cents) and expiring on 31 May 2026, and half being unlisted options exercisable at A$0.035 (3.5 cents) and expiring 31 January 2028. The Placement price represents a 20.8% discount to the 30-day VWAP, 24.6% discount to the 15-day VWAP and 26.2% discount to the last traded price. The funds will be used to accelerate the commercialization of AnteoTech's Life Sciences and Advanced Battery Technology (ABT) products and technologies globally, supporting revenue growth initiatives and strategic partnership development. Near-term targets for the second half of FY26 include converting current ABT and Life Sciences potential customer trials to initial commercial supply agreements, trialling and initial commercial supply into the US market of the joint product developed with Black Diamond Structures, and progressing strategic partnership discussions in the drone, wearable and EV battery segments.

The capital raised will allow AnteoTech to accelerate sales initiatives and progress strategic discussions by supporting qualification and engagement programs, leading to the securing of new sales and partnerships globally in CY2026.